ResearcherTohoku UniversityActive in the last 2 years

Taku Kano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-7859-0805; OpenAlex author ID A5091440577. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2025: 1 paper

Papers 1

A case of FGFR2 fusion-positive pancreatic head tumor with difficult differential diagnosis between cholangiocarcinoma and pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12328-025-02193-0 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Masahiro Iseki · 1 shared paper, 2025 · strength 0.25
- Paper A case of FGFR2 fusion-positive pancreatic head tumor with difficult differential diagnosis between cholangiocarcinoma … DOI 10.1007/s12328-025-02193-0 ↗
Masamichi Mizuma · 1 shared paper, 2025 · strength 0.25
- Paper A case of FGFR2 fusion-positive pancreatic head tumor with difficult differential diagnosis between cholangiocarcinoma … DOI 10.1007/s12328-025-02193-0 ↗
Shuichi Aoki · 1 shared paper, 2025 · strength 0.25
- Paper A case of FGFR2 fusion-positive pancreatic head tumor with difficult differential diagnosis between cholangiocarcinoma … DOI 10.1007/s12328-025-02193-0 ↗
Michiaki Unno · 1 shared paper, 2025 · strength 0.25
- Paper A case of FGFR2 fusion-positive pancreatic head tumor with difficult differential diagnosis between cholangiocarcinoma … DOI 10.1007/s12328-025-02193-0 ↗
Atsushi Masamune · 1 shared paper, 2025 · strength 0.25
- Paper A case of FGFR2 fusion-positive pancreatic head tumor with difficult differential diagnosis between cholangiocarcinoma … DOI 10.1007/s12328-025-02193-0 ↗
Toru Furukawa · 1 shared paper, 2025 · strength 0.25
- Paper A case of FGFR2 fusion-positive pancreatic head tumor with difficult differential diagnosis between cholangiocarcinoma … DOI 10.1007/s12328-025-02193-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.